|
|
|
Nanotechnology: Science, Policy & Public Perspective
A One Day Symposium Hosted by Monash University Institute for Nanosciences, Materials & Manufacture, the Monash Centre for Regulatory Studies and the Faculty of Arts School of Political and Social Inquiry
All presentations will be podcast by Future Materials
| 8.30am |
Registration and Welcome Tea and Coffee |
|
9.00 - 9.05am
|
Opening remarks from session chair
Dr Diana Bowman Monash Centre for Regulatory Studies, Faculty of Law, Monash University
|
|
9.05-9.15am
|
Formal Welcome [audio]
Dr Alan Finkel Chancellor, Monash University
|
|
9.15-10.00am
|
Keynote Address: ‘Nanotechnology risks, ethics and law’
Professor Michael Mehta Principal, Richardson College for the Environment, University of Winnipeg
|
Morning Session: The Science of the Small
|
10.00-10.20am
|
The relevance of nanotechnology to our manufacturing sector
A/Professor Paul Pigram
Director, Centre for Materials and Surface Science, La Trobe University
|
10.20-10.40am |
Morning Tea
|
|
10.40-11.00am
|
What novel biomaterials can be created by nanotechnology?
Dr Keith McLean
Research Theme Leader, Biomedical Materials, CSIRO
|
|
11.00-11.20am
|
How will nanotechnology influence the field of pharmaceutical science?
Dr Paul White
Department of Pharmaceutical Biology, Faculty of Pharmacy and Pharmaceutical
Sciences, Monash University
|
11.20-11.40am
|
What will nanomedicines look like?
Speaker to be confirmed.
|
|
11.40-12.00pm
|
Toxicological considerations in development of nanotechnology products
Professor Brian Priestly
Australian Centre for Human Health Risk Assessment, Department of Epidemiology
and Preventive Medicine, Monash University
|
12.00-12.10pm |
Closing remarks from session chair and from audience
|
12.10-1.00pm |
Lunch
|
Afternoon Session: Policy, Perceptions and Prospects
|
1.00-1.10pm
|
Opening remarks from session chair
Dr Abid Khan
Director, Monash Institute for Nanosciences, Materials and Manufacture, Monash University
|
1.10-1.30pm
|
National dimensions
Peter Chesworth
General Manager, Pharmaceuticals and Enabling Technologies Branch, DIISR
|
1.30-1.50pm
|
Nanotechnology risk assessment
Ms Margaret Stebbing
Australian Centre for Human Health Risk Assessment, Department of Epidemiology
and Preventive Medicine, Monash University
|
1.50-2.10pm
|
Regulatory dimensions
Dr Karinne Ludlow
Monash Centre for Regulatory Studies, Faculty of Law, Monash University
|
2.10-2.30pm
|
Early warnings/lessons from the past: can nanotechnology break the mould?
Dr Rye Senjen
Friends of the Earth Australia
|
2.30-2.50pm |
Tea and Coffee
|
2.50-3.10pm
|
Influences on public acceptance of nanotechnology
Professor Alan Petersen
Chair in Sociology, School of Political and Social Inquiry, Monash University
|
3.10-3.30pm
|
Nanotechnology and OHS - Heed the lessons of the past
Steve Mullins
Australian Council of Trade Unions
|
3.30-3.40pm |
Closing remarks from session chair (Abid Khan) and from audience
|
Industry Panel and Formal Close
|
3.40-3.45pm
|
Opening remarks
Dr Peter Binks
CEO, Nanotechnology Victoria
|
3.45-4.00pm
|
The intellectual property landscape
Mark Roberts
Partner, Davies Collison Cave, Patent and Trade Mark Attorneys
|
4.00-4.50pm
|
Industry Panel: The big picture - markets, policy and innovation pressures
Chair: Dr Peter Binks (CEO, Nanovic)
Panel: Dr Roger Drew (Toxikos; Adjunct Professor in Biochem Toxicology, RMIT)
Dr Richard Taylor (CTO, Mesaplexx)
Dr Erol Harvey (CEO, miniFAB)
Dr Karl Foger (CTO, Ceramic Fuel Cells)
* Other panellists to be confirmed.
|
4.50-5.00pm
|
Formal close
Professor Michael Mehta
|
Drinks and Canapés in the Law Chambers
|